Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy.
Antonelli
Alessandro
A
Metabolism Unit, Department of Internal Medicine, University of Pisa, Pisa, Italy. a.antonelli@med.unipi.it
Ferri
Clodoveo
C
Fallahi
Poupak
P
D000998:Antiviral Agents / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D011092:Polyethylene Glycols / Q000009:adverse effects*; D015995:Prevalence; D011994:Recombinant Proteins; D013967:Thyroiditis, Autoimmune / Q000139:chemically induced* / Q000453:epidemiology
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a